IDA
GILD icon

Intelligence Driven Advisers’s Gilead Sciences GILD Stock Holding History

Intelligence Driven Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$431K Sell
2,891
-389
-12% -$54.6K 0.07% 79
2026
Q2 		$414K Sell
3,280
-1,282
-28% -$169K 0.07% 90
2026
Q1 		$636K Buy
4,562
+1,665
+57% +$233K 0.11% 59
2025
Q4 		$356K Buy
2,897
+476
+20% +$57.8K 0.05% 91
2025
Q3 		$269K Buy
2,421
+186
+8% +$21.1K 0.04% 97
2025
Q2 		$248K Buy
+2,235
New +$238K 0.04% 98

Other funds holding GILD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
CA
CapWealth Advisors Franklin, Tennessee $1.32B AUM 21.6% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
VWM
Valley Wealth Managers Paramus, New Jersey $1.76B AUM 33.82% 1-Year Est. Return
SCA
Stokes Capital Advisors Greenwood, South Carolina $455M AUM 9.69% 1-Year Est. Return

Intelligence Driven Advisers's GILD Position: Q3 2026 in Review

Intelligence Driven Advisers reduced its Gilead Sciences (GILD) stake by 12% in Q3 2026, selling an estimated $54.6K and leaving 2,891 shares worth $431K. The position accounts for 0.07% of the portfolio, ranked #79.

Intelligence Driven Advisers first reported a position in GILD in Q2 2025 and has held it in 6 quarters since. The position peaked at $636K in Q1 2026. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Intelligence Driven Advisers held 2,891 shares of Gilead Sciences worth $431K as of Q3 2026.
  • Intelligence Driven Advisers sold 389 Gilead Sciences shares in Q3 2026, an estimated $54.6K.
  • Gilead Sciences made up 0.07% of Intelligence Driven Advisers's portfolio in Q3 2026, its #79 holding.
  • Intelligence Driven Advisers first reported a position in Gilead Sciences in Q2 2025 and has held it in 6 quarters since.
  • Intelligence Driven Advisers's Gilead Sciences position peaked at $636K in Q1 2026.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Intelligence Driven Advisers's 13F filing for Q3 2026, filed 9 Oct 2026.